4//SEC Filing
Stalfort John A III 4
Accession 0001415889-24-015041
CIK 0001806310other
Filed
May 30, 8:00 PM ET
Accepted
May 31, 4:18 PM ET
Size
8.4 KB
Accession
0001415889-24-015041
Insider Transaction Report
Form 4
Stalfort John A III
Director
Transactions
- Award
Stock Option (right to buy)
2024-05-29+98,440→ 98,440 totalExercise: $3.17Exp: 2034-05-29→ Common Stock (98,440 underlying) - Award
Common Stock
2024-05-29+49,220→ 1,098,601 total
Holdings
- 884,290(indirect: See footnote)
Common Stock
Footnotes (3)
- [F1]Represents a restricted stock unit ("RSU") award. The RSUs will vest on the earlier of May 29, 2025 or the next annual stockholders meeting, subject to the Reporting Person's continued service as a director through the applicable vesting date.
- [F2]The securities are held by Gineane Holly Stalfort, as Trustee of the John A. Stalfort III 2018 Irrevocable Trust under agreement dated as of October 25, 2018.
- [F3]The shares vest on the earlier of May 29, 2025 or the next annual stockholders meeting, subject to the Reporting Person's continued service as a director through the applicable vesting date.
Documents
Issuer
Taysha Gene Therapies, Inc.
CIK 0001806310
Entity typeother
Related Parties
1- filerCIK 0001709418
Filing Metadata
- Form type
- 4
- Filed
- May 30, 8:00 PM ET
- Accepted
- May 31, 4:18 PM ET
- Size
- 8.4 KB